Lord, Abbett & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4.74M | Sell |
|
|||||
|
2024
Q1 | $54M | Buy |
|
|||||
|
2023
Q4 | $6.19M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $311K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $5.81M | Sell |
|
|||||
|
2019
Q4 | $8.93M | Sell |
|
|||||
|
2019
Q3 | $8.51M | Buy |
|
|||||
|
2019
Q2 | $7.96M | Buy |
|
|||||
|
2019
Q1 | $5.09M | Buy |
|
|||||
|
2018
Q4 | $4.03M | Sell |
|
|||||
|
2018
Q3 | $7.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $17.5M | Sell |
|
|||||
|
2016
Q2 | $20.2M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $33.1M | Buy |
|
|||||
|
2015
Q3 | $21M | Sell |
|
|||||
|
2015
Q2 | $27.1M | Sell |
|
|||||
|
2015
Q1 | $39.2M | Buy |
|
|||||
|
2014
Q4 | $5.22M | Sell |
|
|||||
|
2014
Q3 | $5.04M | Buy |
|
|||||
|
2014
Q2 | $4.7M | Buy |
|
|||||
|
2014
Q1 | $3.82M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $5.04M | Buy |
|